Long-Term Safety & Efficacy of Apitegromab in Patients With SMA Who Completed Previous Trials of Apitegromab
Trial details
- Registry ID
- NCT05626855
- Drugs studied
- Apitegromab
TrialRedline tracks 6 clinical trials sponsored by Scholar Rock, Inc.: 2 Phase 3, 4 Phase 2.
Company identity has not yet been verified
| Trial | Drugs studied | Status | Primary completion |
|---|---|---|---|
| Long-Term Safety & Efficacy of Apitegromab in Patients With SMA Who Completed Previous Trials of ApitegromabNCT05626855 | Apitegromab | Active not recruiting | 2026-11-01Estimated |
| Efficacy and Safety of Apitegromab in Patients With Later-Onset Spinal Muscular Atrophy Treated With Nusinersen or RisdiplamNCT05156320 | Apitegromab | Completed | 2024-12-18Actual |
| Trial | Drugs studied | Status | Primary completion |
|---|---|---|---|
| A Study to Evaluate How Apitegromab Works in Subjects Who Are Less Than 2 Years Old and Have Spinal Muscular AtrophyNCT07047144 | Apitegromab, Nusinersen, Risdiplam | Recruiting | 2028-11Estimated |
| Phase 2 Study Evaluating Apitegromab for the Treatment of FSHDNCT07435129 | Apitegromab | Recruiting | 2028-06Estimated |
| Efficacy and Safety of Apitegromab for the Treatment of Adults Who Are Overweight or ObeseNCT06445075 | Apitegromab, Tirzepatide | Completed | 2025-03-04Actual |
| An Active Treatment Study of SRK-015 in Patients With Type 2 or Type 3 Spinal Muscular AtrophyNCT03921528 | SRK-015 | Completed | 2021-01-19Actual |
Names as written in the registry records.
NCT07435129 · Scholar Rock, Inc.
Before: Not yet recruiting. After: Recruiting.